Ultrasound-guided Thyroid Cartilage Plane Block for Awake Intubation
Superior Laryngeal Nerve Block
About this trial
This is an interventional prevention trial for Superior Laryngeal Nerve Block focused on measuring Thyroid Cartilage, Superior Laryngeal Nerve, Difficult airway, ultrasound, Awake tracheal intubation
Eligibility Criteria
Inclusion Criteria: Patients scheduled for awake tracheal intubation surgery under general anesthesia. Patients with difficult airways (e.g., limited cervical spine mobility, full stomach, partial airway obstruction, craniofacial deformities or trauma, micrognathia, mouth opening <3cm, Mallampati III or IV classification) posing challenges for mask ventilation or intubation. Age between 18 and 65 years. Gender is not restricted. ASA classification of I or II. Exclusion Criteria: Cardiovascular dysfunction or arterial aneurysms. Mental or neurological disorders or concomitant arterial aneurysms. Infection at the puncture site. Allergy to local anesthetics. Continuous use of antiplatelet or anticoagulant medications preoperatively. Hoarseness or coughing while drinking water. Bronchial asthma. Participation in other clinical trials within the previous 3 months before enrollment 9.r current participation in other clinical trials.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Thyroid Cartilage Plane Block Group (T Group)
the Control Group (C Group)
Ultrasound-guided bilateral Thyroid Cartilage Plane Block is performed using the thyroid cartilage plate as an anatomical landmark. 3ml of 2% lidocaine is injected on the surface of the thyroid cartilage plate. Subsequently, perform fiberoptic bronchoscope-guided oropharyngeal, subglottic, and tracheal surface anesthesia. After completing surface anesthesia, perform fiberoptic bronchoscope-guided tracheal intubation, securing it properly.
Patients in the C Group receive airway surface anesthesia using the fiberoptic bronchoscope-guided local anesthetic spray method throughout the procedure.